BASILEA PHARMACEU earnings per share and revenue

PK5 earnings per share for the last semiannual are -1.71 CHF whereas the estimation was -2.00 CHF which accounts for 14.96% surprise. Company revenue for the same period amounts to 72.86 M CHF despite the estimated figure of 71.93 M CHF. Estimated earnings per share for the next semiannual are 0.94 CHF, and revenue is expected to reach 86.00 M CHF. Also watch annual changes over time to get a bigger picture of PK5 earnings per share and revenue dynamics.